News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
1d
Zacks Investment Research on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...
Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Scientists have found that cutting cysteine triggers fat to burn energy instead of storing it. This shift from white to brown ...
Here's how to stay in a deficit safely. If you’re trying to lose weight, it’s natural to want an efficient solution. During ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results